Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Critical Care Medicine
Authors: Konrad Reinhart, Thilo Menges, Bengt Gardlund, Jan Harm Zwaveling, Mark Smithes, Jean-Louis Vincent, Jose Maria Tellado, Antonio Salgado-Remigio, Reuven Zimlichman, Stuart Withington, Klaus Tschaikowsky, Rainer Brase, Pierre Damas, Hartmut Kupper, Joachim Kempeni, Juergen Eiselstein, Martin Kaul
Institution: Friedrich Schiller University Jena
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2124925985